Table 4. The Risk Factors identified in the univariate analysis.
Survival [days] | <90 | ≥90 | p |
Male recipient [%] | 47 | 76 | 0.001 |
Coronary heart disease [%] | 28 | 9.83 | 0.005 |
Renal insufficiency [%] | 59.38 | 37.18 | 0.019 |
labMELD [median (IQR)] | 28.5 (18.75–32.5) | 15 (10–28) | 0.001 |
NaMELD [median (IQR)] | 29.39 (20.44–34.71) | 18.79 (11.54–29.58) | 0.005 |
suction bag volume* [ml; median (IQR)] | 5000 (1950–8000) | 3000 (1500–6000) | 0.041 |
CIT [hh:min; median (IQR)] | 12:29 (10:08–14:03) | 11:18.5 (09:52.5–13:06) | 0.041 |
DRI [median (IQR)] | 1.92 (1.71–2.09) | 1.84 (1.5–2.06) | 0.069 |
Donor serum Na+ [mmol/L; mean ± SD] | 134,97±5,79 | 148,19±10,45 | +0.028/0.034 |
Donor serum AST [mmol/L; mean ± SD] | 119,84±115,23 | 78,11±91,86 | 0.074 |
Donor serum ALT [mmol/L; mean ± SD] | 63,50±62,34 | 62,31±84,39 | 0.040 |
CIT: cold ischemic time; DRI: donor risk index; hyper-/hyponatremia defined as Na+<135 and >145 mmol/L.
*total volume collected during surgery including ascites, rinsing fluids, and blood.